AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31854356
Drug: MIS seven
RxNorm normalized name: Sevenfact
DrugBank: Coagulation factor VIIa Recombinant Human (DB00036)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MIS seven implants
Trial: 31854356
Drug: Alphadent active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alphadent active implants
Trial: 26249765
Drug: Rabeprazole sterile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole sterile powder for injection (RSPI) 10 mg
Trial: 26249765
Drug: Rabeprazole sterile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole sterile powder for injection (RSPI) 20 mg
Trial: 26249765
Drug: Rabeprazole sterile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole sterile powder for injection (RSPI) 40 mg
Trial: 26249765
Drug: Rabeprazole sterile
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole sterile powder for injection (RSPI) multiple doses 20 mg
Trial: 26249765
Drug: Pariet® 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pariet® 20 mg (control)
Trial: 15380897
Drug: Probiotic Lactobacillus
RxNorm normalized name: Probiotic Lactobacillus Acidophilus Caplets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic Lactobacillus plantarum 299v (ProViva), median volume 3250 ml, median duration 9 days
Trial: 8540748
Drug: Ascoxal (ascorbic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ascoxal (ascorbic acid-containing solution), applied topically 3 times for 2 min on the first day
Trial: 2551988
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg b.i.d. + Indomethacin 50 mg b.i.d.
Trial: 2551988
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg o.i.d. + Indomethacin 50 mg b.i.d.
Trial: 7562679
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg b.i.d.
Trial: 2551988
Drug: Enalapril 20
RxNorm normalized name: enalapril 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 20 mg o.i.d.
Trial: 2551988
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg b.i.d. and Enalapril 20 mg o.i.d.
Trial: 1381763
Drug: Indomethacin 50
RxNorm normalized name: indomethacin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 50 mg b.i.d.
Trial: 749190
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy added to radical mastectomy
Trial: 749190
Drug: Combination chemo-
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemo- or chemo-hormono-therapy
Trial: 749190
Drug: Local therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local therapy alone (surgery with or without postoperative radiotherapy)
Trial: 23233269
Drug: Oxytocin intranasal
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin intranasal spray (20 IU twice a day for the first week, then 40 IU twice a day for the following 7 weeks)
Trial: 23233269
Drug: Oxytocin intranasal
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin intranasal spray
Trial: 23233269
Drug: Placebo intranasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo intranasal spray (normal saline)
Trial: 15056124
Drug: HCA-SX 4667
RxNorm normalized name: SX-682
DrugBank: SX-682 (DB19210)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HCA-SX 4667 mg
Trial: 15056124
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of HCA-SX 4667 mg, NBC 4 mg, and GSE 400 mg
Trial: 11763951
Drug: 1.25 g
RxNorm normalized name: AndroGel 1.25 g Packets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 g dentifrice containing 0.3% triclosan (3.75 mg triclosan dose) - single-dose phase
Trial: 11763951
Drug: Three times
RxNorm normalized name: WELLBUTRIN 100 MG Oral Tablet, Three Times Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three times daily brushing with 1.25 g dentifrice containing 0.3% triclosan - multiple-dose phase
Trial: 11763951
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily brushing with 1 gm of dentifrice containing 0.2% triclosan
Trial: 9574192
Drug: Antibiotic carrier
RxNorm normalized name: Valiant Barrier
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic carrier (group 1)
Trial: 9574192
Drug: No antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotic carrier (group 2)
Trial: 7840418
Drug: Ketamine 1.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 1.3 mg/kg bolus + 4 mg/kg/h continuous for 15 min
Trial: 7840418
Drug: S-(+)-ketamine 0.65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-(+)-ketamine 0.65 mg/kg bolus + 2 mg/kg/h continuous for 15 min
Trial: 7840418
Drug: S-(+)-ketamine 0.65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-(+)-ketamine 0.65 mg/kg bolus + 2 mg/kg/h continuous for 15 min + physostigmine 0.012 mg/kg
Trial: 7840418
Drug: S-(+)-ketamine 0.65
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-(+)-ketamine 0.65 mg/kg bolus + 2 mg/kg/h continuous for 15 min + saline placebo
Trial: 9356091
Drug: verapamil 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 0.1 mg/kg I.V. plus saline
Trial: 9356091
Drug: lidocaine 1
RxNorm normalized name: lidocaine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lidocaine 1 mg/kg I.V. plus saline
Trial: 9356091
Drug: verapamil 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil 0.1 mg/kg I.V. plus lidocaine 1 mg/kg I.V.
Trial: 3954370
Drug: High-dose metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose metoclopramide (2 mg/kg x 4: H)
Trial: 3954370
Drug: Moderate-dose metoclopramide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dose metoclopramide (1 mg/kg x 4: M)
Trial: 28852716
Drug: Dry cupping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dry cupping therapy
Trial: 24808482
Drug: Weekly context-appropriate
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly context-appropriate child-centered counseling (CCC)
Trial: 21251896
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of MET (n = 19) for 4 weeks followed by 100 mg MET for 4 weeks
Trial: 21251896
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg of NEB (n = 22) for 4 weeks followed by 10 mg NEB for 4 weeks
Trial: 16253414
Drug: Urapidil (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil (initial dose of 12.5-25mg)
Trial: 16253414
Drug: Dihydralazine (uniform
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydralazine (uniform initial dose of 5mg)
Trial: 14649341
Drug: Intraperitoneal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal bupivacaine 0.25% plus intravenous morphine 2 mg
Trial: 9007717
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose UDCA (10 mg kg‐1 day‐1) at bed time
Trial: 9007717
Drug: Multiple dose
RxNorm normalized name: Rebetron, multiple dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dose UDCA (10 mg kg‐1 day‐1) in three divided doses with meals
Trial: 6751536
Drug: Fentiazac 100
RxNorm normalized name: fentiazac
DrugBank: Fentiazac (DB13217)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentiazac 100 mg four times a day for one week
Trial: 31682976
Drug: Fosamprenavir administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosamprenavir administered during MMC phase II
Trial: 31682976
Drug: Fosamprenavir administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosamprenavir administered during MMC phase I
Trial: 22562389
Drug: Subcutaneous adalimumab
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous adalimumab injections
Trial: 22562389
Drug: Intraarticular glucocorticoid
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular glucocorticoid injections
Trial: 8172482
Drug: Bepridil (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bepridil (300 mg/day after a loading dose of 900 mg on D1, 500 mg on D2 and D3)
Trial: 6851041
Drug: Diltiazem (360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (360 mg/day)
Trial: 3075350
Drug: Mefloquine (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mefloquine (750 mg) and artemether (600 mg by injection, 200 mg initially and 100 mg every 12 h)
Trial: 3075350
Drug: Quinine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine (10 mg/kg orally every 8 h for 7 d)
Trial: 31470444
Drug: DAPT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAPT plus high-dose edoxaban (60 mg once daily)
Trial: 31470444
Drug: DAPT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAPT plus low-dose edoxaban (30 mg once daily)
Trial: 28827258
Drug: Faecal microbiota
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Faecal microbiota transplantation (FMT) administered via enema, two times per week for 6 weeks.
Trial: 28827258
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline control administered via enema, two times per week for 6 weeks.
Trial: 2185303
Drug: Milnacipran 200
RxNorm normalized name: MILNACIPRAN
DrugBank: Milnacipran (DB04896)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Milnacipran 200 mg/d
Trial: 16634956
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg ibuprofen arginine
Trial: 8826510
Drug: Tenoxicam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam (20 mg) + bromazepan (3 mg)
Trial: 8826510
Drug: Tenoxicam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoxicam (20 mg) + placebo
Trial: 8826510
Drug: Bromazepan (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromazepan (3 mg) + placebo
Trial: 6731021
Drug: Omnipaque 350
RxNorm normalized name: Omnipaque 350
DrugBank: Iohexol (DB01362)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omnipaque 350 mg I/ml
Trial: 6731021
Drug: Urografin 370
RxNorm normalized name: Urografin 370
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urografin 370 mg I/ml
Trial: 31126551
Drug: Urtica dioica
RxNorm normalized name: Urtica Dioica
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urtica dioica 450 mg/day and acupuncture 11 sessions (A)
Trial: 27601217
Drug: Placebo (dextrose,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (dextrose, same dosage)
Trial: 24004044
Drug: Sensor-augmented insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sensor-augmented insulin pump (SAP)
Trial: 21488717
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily injection (MDI) therapy
Trial: 8831474
Drug: Local steroid
RxNorm normalized name: RECTAL,LOCAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local steroid injection plus elbow splinting (Group B)
Trial: 1429485
Drug: Fluoxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (20 mg/day, 40 mg/day, 60 mg/day)
Trial: 4043661
Drug: Vancomycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (500 mg/day)
Trial: 30520413
Drug: Modified self‐management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified self‐management plan advising temporary quadrupling of inhaled corticosteroid dose
Trial: 20578203
Drug: Risk factors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risk factors measured (elevated A(1c), 2‐h PG, fasting insulin (FI), albuminuria, obesity)
Trial: 15921608
Drug: Typhoid Vi
RxNorm normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typhoid Vi vaccine
Trial: 15921608
Drug: Meningococcal A
RxNorm normalized name: MENINGOCOCCAL A/B/C/W/Y (PENBRAYA) KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meningococcal A vaccine
Trial: 11813173
Drug: Prophylactic G-CSF
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic G-CSF administration after chemotherapy intensification
Trial: 10400415
Drug: GM‐CSF at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM‐CSF at a dose of 3 microg/kg s.c. on days 1‐2, rhEpo at a dose of 60 U/kg s.c. on days 3‐5, repeated for a total of 6 weeks, with dose increase to 120 U/kg if Hb rise not achieved.
Trial: 7267677
Drug: Minaprine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minaprine (100 mg per day)
Trial: 27697911
Drug: Alcohol treatment
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol treatment (intoxicated)
Trial: 27484437
Drug: p-synephrine (S;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: p-synephrine (S; 100 mg)
Trial: 27484437
Drug: p-synephrine +
RxNorm normalized name: synephrine
DrugBank: Synephrine (DB09203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: p-synephrine + caffeine (SCF; 100 mg of p-synephrine plus 100 mg of caffeine)
Trial: 23903811
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine dose reduction (20% reduction weekly for 10 weeks)
Trial: 23903811
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no change in morphine dose)
Trial: 19712598
Drug: Pharmaceutical intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmaceutical intervention programme
Trial: 12435255
Drug: Ramipril (2.5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (2.5‐10 mg/d)
Trial: 12435255
Drug: Metoprolol (50‐200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (50‐200 mg/d)
Trial: 12435255
Drug: Amlodipine (5‐10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5‐10 mg/d)
Trial: 10626558
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment at a dose of 0.1 IU/kg/day (0.033 mg/kg/day) for 2 years (Group A)
Trial: 10626558
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment at a dose of 0.2 IU/kg/day (0.066 mg/kg/day) during the second year (Group B)
Trial: 10626558
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment restarted at a dose of 0.1 IU/kg/day (0.033 mg/kg/day) after a 6-month break
Trial: 10626558
Drug: Not applicable
RxNorm normalized name: AIR 1000 mL in 1 L NOT APPLICABLE GAS
DrugBank: Urea (DB03904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Not applicable (GH treatment withdrawn)
Trial: 1951859
Drug: Oral metrifonate
RxNorm normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral metrifonate (10 mg/kg for three doses each year)
Trial: 1951859
Drug: Praziquantel therapy
RxNorm normalized name: Praziquantel
DrugBank: Praziquantel (DB01058)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Praziquantel therapy (40 mg/kg as a single dose each year)
Trial: 7197489
Drug: Droperidol, 2.5
RxNorm normalized name: Droperidol, 2.5 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol, 2.5 mg IM
Trial: 7197489
Drug: Hydroxyzine, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyzine, 100 mg IM
Trial: 29805252
Drug: Active buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active buprenorphine 5 µg/hour
Trial: 28099979
Drug: Intravenous milrinone
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous milrinone lactate (low dose: 20 mcg/kg bolus followed by 0.2 mcg/kg/minute)
Trial: 28099979
Drug: Intravenous milrinone
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous milrinone lactate (standard dose: 50 mcg/kg bolus followed by 0.5 mcg/kg/minute)
Trial: 26268533
Drug: Agomelatine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine (25 mg)
Trial: 16117817
Drug: Agomelatine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine (50 mg)
Trial: 10405745
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of 2 mL/kg of 300 mg iodine/mL contrast material at 5 mL/sec (Group 1)
Trial: 10405745
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of 2 mL/kg of 300 mg iodine/mL contrast material at 3 mL/sec (Group 2)
Trial: 10405745
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of 1.5 mL/kg of 300 mg iodine/mL contrast material at 5 mL/sec (Group 3)
Trial: 10405745
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of 1.5 mL/kg of 300 mg iodine/mL contrast material at 3 mL/sec (Group 4)
Trial: 31811673
Drug: Ibuprofen plus
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen plus acetaminophen
Trial: 30955985
Drug: Ibuprofen plus
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen plus placebo
Trial: 28410922
Drug: Artichoke Leaf
RxNorm normalized name: artichoke leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artichoke Leaf Extract (ALE) 1800 mg (four tablets per day)
Trial: 28410922
Drug: Placebo (cornstarch,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (cornstarch, lactose, and avicel, four tablets per day)
Trial: 27681579
Drug: Dovitinib capsule
RxNorm normalized name: Dovitinib
DrugBank: Dovitinib (DB05928)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dovitinib capsule (500 mg once daily on a 5-days-on/2-days-off schedule)
Trial: 27681579
Drug: Dovitinib tablet
RxNorm normalized name: Dovitinib
DrugBank: Dovitinib (DB05928)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dovitinib tablet (500 mg once daily on a 5-days-on/2-days-off schedule)
Trial: 27681579
Drug: Dovitinib (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dovitinib (both formulations)
Trial: 22154243
Drug: Monophasic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monophasic preparation containing 30μg ethinylestradiol and 150μg desogestrel (DG/EE)
Trial: 22154243
Drug: Monophasic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monophasic preparation containing 30μg ethinylestradiol and 150μg levonogestrel (LNG/EE)
Trial: 20223599
Drug: High-dose corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose corticosteroid therapy (methylprednisolone)
Trial: 20223599
Drug: Alternative therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative therapy (mitoxantrone)
Trial: 20223599
Drug: Major depression
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Major depression (MD) receiving antidepressants
Trial: 15878492
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of thermal water (active group, n=20)
Trial: 15878492
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of thermal water (active group)
Trial: 10465168
Drug: n-3 polyunsaturated
RxNorm normalized name: Omega-3 (n-3) polyunsaturated fatty acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 polyunsaturated fatty acids (1 g daily, n=2836)
Trial: 10465168
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (n-3 PUFA and vitamin E, n=2830)
Trial: 10465168
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (300 mg daily, n=2830)
Trial: 30527287
Drug: Polyherbal combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyherbal combination tablets
Trial: 30457892
Drug: Turmeric tablets
RxNorm normalized name: Nature's Way Turmeric Tablets
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turmeric tablets
Trial: 28096034
Drug: Self-referral to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-referral to inpatient treatment (SRIT) contract
Trial: 22030384
Drug: Tibolone 2.5mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 2.5mg daily